Michael Keng, MD
Associate Professor
Focus is on clinical trials in hematologic malignancies, including myelodysplastic syndromes and leukemias. Special interest in treating the elderly population, determining optimal combinations and timing of targeted agents in MDS and leukemia, and studying patient safety and quality improvement.
Dr. Michael Keng holds a clinical faculty appointment in Medicine in the Division of Hematology/Oncology at UVA Cancer Center. He practices at the Emily Couric Clinical Cancer Center in Charlottesville and serves as an inpatient hematologist at UVA Hospital. His clinical areas of interest are: myelodysplastic syndromes, myeloproliferative disorders, acute myeloid leukemia, chronic myeloid leukemia, acute lymphoid leukemia, and aplastic anemia. He attended medical school at Michigan State University in East Lansing, Michigan and completed internal medicine residency at University of Southern California in Los Angeles, California. He completed fellowship in Hematology and Medical Oncology at the Cleveland Clinic, Cleveland, Ohio, in 2014, where he served as chief fellow from 2013-2014. Dr. Keng joined the University of Virginia in 2014. He lives with his wife and daughter and enjoys cooking, hiking, and travelling.
UVA Health - Emily Couric Cancer Center: 1240 Lee St, Charlottesville, VA 22903, USA
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.